Peer Review | Agreement Across 10 Artificial Intelligence Models in Assessing Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Breast Cancer Whole-Slide Images
Friends of Cancer Research Response to National Cancer Institute’s Request for Information: Benchmarks for Artificial Intelligence in Cancer Research and Care
Public Comment | Request for Information on the Development of an Artificial Intelligence (AI) Action Plan Ensuring Efficient and Innovative Regulatory Approaches for AI in Drug Development
The integration of Artificial Intelligence (AI) and Machine Learning (ML) into drug development and diagnostics presents unprecedented opportunities to enhance patient care, streamline drug discovery, and improve the accuracy of diagnosis and treatment selection. However, these technologies may require a new regulatory paradigm, particularly given their adaptive nature. To ensure safety, efficacy, and reliability, regulatory…